HEALTH CARE WEEK IN REVIEW: F.D.A. Advisory Panel Gives Green Light to Pfizer Vaccine, U.S. Surpasses 3,000 COVID Deaths In A Day for the First Time, FDA Authorizes First At-Home COVID-19 Test Available Without A Prescription, HHS Proposes Changing HIPAA Privacy Rules
Source: Getty Images
Here's The Latest in Health Care:
• Pfizer’s Covid-19 vaccine passed a critical milestone this week when a panel of experts formally recommended that the Food and Drug Administration authorize the vaccine. The agency is likely to do so within days, giving health care workers and nursing home residents first priority to begin receiving the first shots early next week. Read More
• The U.S. passed yet another gruesome pandemic milestone, with states reporting more than 3,000 coronavirus deaths in a single day for the first time. The extraordinary death count represents an all-time high for the pandemic, which is also expected to pass the tragic point of 300,000 deaths in the coming week. Read More
• No search for an open COVID-19 testing center. No waiting in line. No need to even venture outside the house, in fact. That's the promise of LabCorp's Pixel test, which has secured an FDA green light for home delivery without a prescription, the first test to reach that milestone. Read More
• HHS has proposed changes to HIPAA rules that aim to improve care coordination and give patients more access to their health information. The goal is to enable greater family and caregiver involvement in the care of individuals experiencing emergencies or health crises and boost flexibilities for disclosures in emergency or threatening circumstances. Read More
Each Friday, Signor Goat reports the latest from the week in health care. Check back next Friday for your dose of our little medical corner of health care news. Brought to you by pMD, innovators in charge capture, secure messaging, clinical communication, and care navigation software.
